ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis

Tuesday, September 15, 2020

Submitted by

Aristotle Protopapas

Source

Source Name: Circulation

Source URL: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.046308

Author(s)

Safi U. Khan, Maninder Singh, Shahul Valavoor, Muhammad U. Khan, Ahmad N. Lone, Muhammad Zia Khan, Muhammad Shahzeb Khan, Preethi Mani, Samir R. Kapadia, Erin D. Michos, Gregg W. Stone, Ankur Kalra, and Deepak L. Bhatt

An open-access large metanalysis on the utility and risks of antiplatelets after PCI. Of note, mortality was not a primary endpoint. The message is that long dual antiplatelet use is an exchange between avoidance of myocardial events and serious bleeding.

The novel oral anticoagulants may enter the arena soon..